Which Strategies Should Be Implemented in Latin America to Eradicate Hepatitis C Virus by 2030?
Ezequiel Ridruejo, Alejandro Soza – 9 September 2020
Family Counseling for Hepatitis B and Hepatitis C
Tatyana Kushner, Rhoda S. Sperling, Douglas Dieterich – 9 September 2020
Approach to Hyponatremia in Cirrhosis
Bashar Attar – 9 September 2020
Looking for the Best Model to Predict Hepatocellular Carcinoma Recurrence After Liver Transplantation in Latin America
Federico Piñero, Aline Chagas, Ilka Boin – 9 September 2020
Con: Liver Biopsy Remains the Gold Standard to Evaluate Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Daniel Berger, Vishal Desai, Sujit Janardhan – 9 September 2020
ALT Levels for Asians With Metabolic Diseases: A Meta‐analysis of 86 Studies With Individual Patient Data Validation
Daniel Q. Huang, Yee Hui Yeo, Eunice Tan, Hirokazu Takahashi, Satoshi Yasuda, Junji Saruwatari, Kenichi Tanaka, Kentaro Oniki, Leslie Y. Kam, Mark D. Muthiah, Hideyuki Hyogo, Masafumi Ono, Scott D. Barnett, Jie Li, Biyao Zou, James Fung, Teng‐Yu Lee, Vincent Wai‐Sun Wong, Man‐Fung Yuen, Yock Young Dan, Seng Gee Lim, Ramsey Cheung, Hidenori Toyoda, Yuichiro Eguchi, Mindie H. Nguyen – 9 September 2020 – The current alanine aminotransferase (ALT) upper limit of normal was defined using selected healthy Caucasian blood donors.
Pro: Noninvasive Imaging Has Replaced Biopsy as the Gold Standard in the Evaluation of Nonalcoholic Fatty Liver Disease
Shaham Mumtaz, Nathan Schomaker, Natasha Von Roenn – 9 September 2020
Pro: Noninvasive Imaging Has Replaced Biopsy as the Gold Standard in the Evaluation of Nonalcoholic Fatty Liver Disease
Shaham Mumtaz, Nathan Schomaker, Natasha Von Roenn – 9 September 2020